Big Pharma strikes back with data secrecy [Off Topic]

posted by mittyri  – Russia, 2019-10-28 11:13 (2020 d 22:24 ago) – Posting: # 20727
Views: 5,781
(edited on 2019-10-28 12:59)

Hi all,

Some EMA news

If the Court of Justice upholds the view that CSRs [clinical study reports] should benefit from a general presumption of confidentiality, it would change the rules of the game. Sadly, such a move could easily take us back to a situation where disclosure of clinical trial data is the exception, instead of being the norm.

See here
—
Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
120 visitors (0 registered, 120 guests [including 5 identified bots]).
Forum time: 10:38 CEST (Europe/Vienna)

We should not speak so that it is possible
for the audience to understand us,
but so that it is impossible
for them to misunderstand us.    Quintilian

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5